CY1110499T1 - Παρασκευασματα γελης 4-υδροξυ ταμοξιφενης - Google Patents

Παρασκευασματα γελης 4-υδροξυ ταμοξιφενης

Info

Publication number
CY1110499T1
CY1110499T1 CY20091100201T CY091100201T CY1110499T1 CY 1110499 T1 CY1110499 T1 CY 1110499T1 CY 20091100201 T CY20091100201 T CY 20091100201T CY 091100201 T CY091100201 T CY 091100201T CY 1110499 T1 CY1110499 T1 CY 1110499T1
Authority
CY
Cyprus
Prior art keywords
hydroxy tamoxifen
gel preparations
tamoxifen gel
preparations
hydroxy
Prior art date
Application number
CY20091100201T
Other languages
English (en)
Inventor
Valérie Masini-Eteve
Original Assignee
Laboratoires Besins International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292447A external-priority patent/EP1647271A1/en
Application filed by Laboratoires Besins International filed Critical Laboratoires Besins International
Publication of CY1110499T1 publication Critical patent/CY1110499T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με φαρμακευτικές ενώσεις και γέλες που περιέχουν (4-υδροξυ ταμοξιφένη) καθώς και μεθόδους χρήσης αυτών.
CY20091100201T 2004-10-14 2009-02-20 Παρασκευασματα γελης 4-υδροξυ ταμοξιφενης CY1110499T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292447A EP1647271A1 (en) 2004-10-14 2004-10-14 4-Hydroxy tamoxifen gel formulations
US63835904P 2004-12-23 2004-12-23
EP05803579A EP1799201B1 (en) 2004-10-14 2005-10-13 4-hydroxy tamoxifen gel formulations

Publications (1)

Publication Number Publication Date
CY1110499T1 true CY1110499T1 (el) 2015-04-29

Family

ID=35501209

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100201T CY1110499T1 (el) 2004-10-14 2009-02-20 Παρασκευασματα γελης 4-υδροξυ ταμοξιφενης

Country Status (24)

Country Link
EP (1) EP1799201B1 (el)
JP (1) JP5047800B2 (el)
KR (1) KR101294947B1 (el)
AT (1) ATE415156T1 (el)
AU (1) AU2005293712B2 (el)
BR (1) BRPI0518139B1 (el)
CA (1) CA2582174C (el)
CY (1) CY1110499T1 (el)
DE (1) DE602005011314D1 (el)
DK (1) DK1799201T3 (el)
EA (1) EA011295B1 (el)
ES (1) ES2318563T3 (el)
GE (1) GEP20104889B (el)
HK (1) HK1103027A1 (el)
HR (1) HRP20090239T1 (el)
IL (1) IL182298A (el)
MA (1) MA28927B1 (el)
MX (1) MX2007004371A (el)
NO (1) NO338755B1 (el)
PL (1) PL1799201T3 (el)
PT (1) PT1799201E (el)
SI (1) SI1799201T1 (el)
TN (1) TNSN07139A1 (el)
WO (1) WO2006040196A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
KR101304536B1 (ko) * 2011-06-03 2013-09-24 전남대학교산학협력단 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 간질환의 치료 또는 예방용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
EP2050443B1 (en) * 2002-12-18 2017-05-24 Besins Healthcare Luxembourg SARL Reduction of breast density with 4-hydroxy tamoxifen
NZ540494A (en) * 2002-12-18 2007-05-31 Besins Int Lab Treatment of mastalgia with 4-hydroxy tamoxifen
ES2456957T3 (es) * 2003-04-01 2014-04-24 Besins Healthcare Luxembourg Sarl Tratamiento de cáncer de seno con 4-hidroxitamoxifen
PL1694319T3 (pl) * 2003-12-15 2009-01-30 Besins Healthcare Lu Sarl Zastosowanie 4-hydroksytamoksyfenu do wytwarzania leku do leczenia ginekomastii
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
PL1748770T3 (pl) * 2004-03-22 2008-09-30 Besins Healthcare Lu Sarl Leczenie i zapobieganie dobrotliwej chorobie sutka 4-hydroksytamoksyfenem
EP1579857A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Chemically stable compositions of 4-hydroxy tamoxifen

Also Published As

Publication number Publication date
HRP20090239T1 (en) 2009-06-30
WO2006040196A1 (en) 2006-04-20
IL182298A (en) 2013-01-31
JP5047800B2 (ja) 2012-10-10
KR20070068366A (ko) 2007-06-29
CA2582174A1 (en) 2006-04-20
EA200700834A1 (ru) 2007-10-26
KR101294947B1 (ko) 2013-08-09
NO338755B1 (no) 2016-10-17
HK1103027A1 (en) 2007-12-14
AU2005293712A1 (en) 2006-04-20
PL1799201T3 (pl) 2009-05-29
DE602005011314D1 (de) 2009-01-08
BRPI0518139A (pt) 2008-10-28
BRPI0518139B1 (pt) 2021-10-13
GEP20104889B (en) 2010-02-10
ATE415156T1 (de) 2008-12-15
AU2005293712B2 (en) 2011-04-21
EP1799201A1 (en) 2007-06-27
JP2008525316A (ja) 2008-07-17
ES2318563T3 (es) 2009-05-01
EA011295B1 (ru) 2009-02-27
MX2007004371A (es) 2007-06-07
TNSN07139A1 (en) 2008-11-21
IL182298A0 (en) 2007-07-24
EP1799201B1 (en) 2008-11-26
SI1799201T1 (sl) 2009-06-30
NO20072463L (no) 2007-05-14
MA28927B1 (fr) 2007-10-01
PT1799201E (pt) 2009-02-26
DK1799201T3 (da) 2009-03-30
CA2582174C (en) 2013-01-29

Similar Documents

Publication Publication Date Title
SE0301653D0 (sv) Novel compounds
CY1112721T1 (el) Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα
SE0301700D0 (sv) Novel compounds
CY1112653T1 (el) Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
NO20091976L (no) Nye forbindelser
CY1110225T1 (el) Κυκλικοι αναστολεις πρωτεϊνικης τυροσινικης κινασης
CY1114669T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
CY1112862T1 (el) Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
ATE497489T1 (de) Nichtsymmetrisches geliermittel
NO20055741D0 (no) Nye kjemiske forbindelser
CY1113533T1 (el) Ετεροαρυλο-υποκατεστημενα παραγωγα κυκλοεξυλο-1,4-διαμινης
CY1109465T1 (el) Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
EA200801414A1 (ru) Кальцилитические соединения
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
CY1120368T1 (el) Αλληλουχια ειδικης διασπασης μμρ-14
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
EA200870058A1 (ru) Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран
SE0301650D0 (sv) Novel compounds
EA200501301A1 (ru) Ментоловые растворы лекарственных препаратов